In The Orphan Drug Approval Race, Winner Takes All? Ramifications Of Catalyst Pharms. V. Becerra - Food, Drugs, Healthcare, Life Sciences
How is orphan drug exclusivity affected when the FDA-approved use for an orphan drug is arguably narrower than the treatment of the rare disease it was designated for.
Source: mondaq.com